ARCHIVES

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

Year 2000 Objectives In Health On Track

June 25, 1999

“Alternative” Is Misleading Term, President’s Cancer Panel Writes To Healy

February 5, 1993

Public Participation Hearings Develop Gals for Reducing Cancer Mortality

February 17, 1989

Evaluation Finds OIG Provides PIs With Flexibility

June 14, 1991

Constance Percy Retires From NCI After 30 Years.

November 10, 2000

House Panel Recommends $642 Million Increase For NIH; $31 Million Increase For NCI

July 21, 1995